Financials SMAIO

Equities

ALSMA

FR0014005I80

Pharmaceuticals

Real-time Euronext Paris 05:12:54 2024-07-11 am EDT 5-day change 1st Jan Change
3.88 EUR +1.57% Intraday chart for SMAIO +5.15% +25.97%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 16.99 16.1 19.92 - -
Enterprise Value (EV) 1 11.95 16.1 19.62 21.22 21.32
P/E ratio - 15.2 x -9.79 x 38.2 x 10.9 x
Yield - - - - -
Capitalization / Revenue 7.08 x 2.99 x 3.69 x 1.93 x 1.54 x
EV / Revenue 4.98 x 2.99 x 3.63 x 2.06 x 1.65 x
EV / EBITDA -4.7 x 7.82 x -16.4 x 15.2 x 7.62 x
EV / FCF 2.34 x - -5.77 x -12.5 x -213 x
FCF Yield 42.7% - -17.3% -8.01% -0.47%
Price to Book - - - - -
Nbr of stocks (in thousands) 5,229 5,229 5,215 - -
Reference price 2 3.250 3.080 3.820 3.820 3.820
Announcement Date 4/11/23 4/29/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 2.1 2.4 5.383 5.4 10.3 12.9
EBITDA 1 - -2.544 2.059 -1.2 1.4 2.8
EBIT 1 - -4 0.7368 -2.4 0.2 1.4
Operating Margin - -166.67% 13.69% -44.44% 1.94% 10.85%
Earnings before Tax (EBT) - - - - - -
Net income 1 -3.1 2.846 1.058 -2 0.5 1.8
Net margin -147.62% 118.57% 19.66% -37.04% 4.85% 13.95%
EPS 2 - - 0.2024 -0.3900 0.1000 0.3500
Free Cash Flow 1 - 5.106 - -3.4 -1.7 -0.1
FCF margin - 212.73% - -62.96% -16.5% -0.78%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - 179.42% - - - -
Dividend per Share - - - - - -
Announcement Date 4/29/22 4/11/23 4/29/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - 1.3 1.4
Net Cash position 1 - 5.04 - 0.3 - -
Leverage (Debt/EBITDA) - - - - 0.9286 x 0.5 x
Free Cash Flow 1 - 5.11 - -3.4 -1.7 -0.1
ROE (net income / shareholders' equity) - 29.2% - - 5.8% 16.5%
ROA (Net income/ Total Assets) - - - - 4.6% 13.1%
Assets 1 - - - - 10.87 13.74
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - 0.83 - 1.5 1.5 1.5
Capex / Sales - 34.59% - 27.78% 14.56% 11.63%
Announcement Date 4/29/22 4/11/23 4/29/24 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.82 EUR
Average target price
5.8 EUR
Spread / Average Target
+51.83%
Consensus

Annual profits - Rate of surprise